The global family planning community is working to ensure that more women around the world have access to contraceptive options and family planning services and information. As part of this global effort, a group of organizations collaborated to make contraceptive implants—a previously less accessible family planning option—more available to women in the world’s poorest countries.
Since the launch of the Implant Access Program (IAP) in 2013, tremendous progress has been made toward expanding contraceptive access and options and strengthening global family planning systems overall.
A group of public and private organizations collaborated to make Bayer Pharma’s Jadelle® and MSD’s Implanon® and Implanon NXT® available to women in the world’s poorest countries at price reductions of approximately 50% through 2018.
Other organizations involved in the agreement include: the Bill & Melinda Gates Foundation; the Clinton Health Access Initiative (CHAI); the governments of Norway, Sweden, the United Kingdom and the United States; and the Children’s Investment Fund Foundation (CIFF), with support from the United Nations Population Fund (UNFPA). The IAP supports the recommendations of the UN Commission on Life-Saving Commodities to increase the availability of quality, life-saving commodities for women’s and children’s health.
IAP has been tracking its progress since its launch in 2013. Explore the links below for updates on its work.